UPTAKE: Using Personalized Risk and Digital Tools to Guide Transitions Following Acute Kidney Events | MicrobiomeTrials← Back to trialsNCT05806645
UPTAKE: Using Personalized Risk and Digital Tools to Guide Transitions Following Acute Kidney Events
RecruitingNAINTERVENTIONAL
Trial Details
Start: 2025-02-12Est. Completion: 2028-09
Enrollment target: 6,046 participants Locations- Foothills Medical Centre, Calgary, Alberta, Canada
- University of Alberta Hospital, Edmonton, Alberta, Canada
Other microbiome trials you might be interested in
Acute Kidney InjuryContrast-induced Nephropathy
This study will involve measurement of levels of a novel urinary biomarker of renal ischemia, L-FABP. The purpose of the…
Chandler, United StatesCompleted Feb 5, 2026
Minimal Change Disease (MCD)Membranous NephropathyGlomerulosclerosis, Focal Segmental
Minimal change disease (MCD), focal segmental glomerulosclerosis (FSGS), and Membranous nephropathy (MN), generate an en…
Los Angeles, United StatesEst. completion Dec 31, 2030